| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |